Erratum: Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin (Human Molecular Genetics (2006)15,:20 (3041-3054) DOI: 10.1093/hmg/ddl246);Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin

Human Molecular Genetics

Volumn 15, Issue 20, 2006, Pages 3041-3054

  Talbot, Konrad ^a   Cho, Dan Sung ^a   Ong, Wei Yi ^b   Benson, Matthew A ^c   Han, Li Ying ^a   Kazi, Hala A ^a   Kamins, Joshua ^a   Hahn, Chang Gyu ^a   Blake, Derek J ^c   Arnold, Steven E ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Translational Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BRAIN PROTEIN; DYSBINDIN 1; MICROTUBULE PROTEIN; SNAPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN TISSUE; CELL DENSITY; CELL LABELING; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IN VITRO STUDY; MALE; MOUSE; NERVE CELL MEMBRANE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SYNAPSE VESICLE; TISSUE DISTRIBUTION;

EID: 33749563041     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddad064     Document Type: Erratum

References (68)

1. Benson, M.A., Newey, S.E., Martin-Rendon, E., Hawkes, R. and Blake, D.J. (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem., 276, 24232-24241.
2. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
3. Darras, B.T., Menache, C.C. and Kunkel, L.M. (2003) Dystrophinopathies. In Jones, H.R., Jr., DeVivo, D.C. and Darras, B.T. (eds), Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach, Butterworth/Heinemann, New York, pp. 649-699.
4. Blake, D.J., Hawkes, R., Benson, M.A. and Beesley, P.W. (1999) Different dystrophin-like complexes are expressed in neurons and glia. J. Cell. Biol., 147, 645-658.
5. Brünig, I., Suter, A., Knuesel, I., Luscher, B. and Fritschy, J.M. (2002) GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA (A) receptors and gephyrin. J. Neurosci., 22, 4805-4813.
6. Lidov, H.G. (1996) Dystrophin in the nervous system. Brain Pathol., 6, 63-77.
7. Marchand, S., Stetzkowski-Marden, F. and Cartaud, J. (2001) Differential targeting of components of the dystrophin complex to the postsynaptic membrane. Eur. J. Neurosci., 13, 221-229.
8. Straub, R.E., Jiang, Y., MacLean, C.J., Ma, Y., Webb, B.T., Myakishev, M.V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B. et al. (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet., 71, 337-348.
9. Williams, N.M., O'Donovan, M.C. and Owen, M.J. (2005) Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophr. Bull., 31, 800-805.
10. Hall, D., Gogos, J.A. and Karayiorgou, M. (2004) The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav., 3, 240-248.
11. Li, T., Zhang, F., Liu, X., Sun, X., Sham, P.C., Crombie, C., Ma, X., Wang, Q., Meng, H., Deng, W. et al. (2005) Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol. Psychiatry, 10, 1037-1044.
12. Harrison, P.J. and Weinberger, D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol. Psychiatry, 10, 40-68.
13. Bray, N.J., Preece, A., Williams, N.M., Moskvina, V., Buckland, P.R., Owen, M.J. and O'Donovan, M.C. (2005) Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet., 14, 1947-1954.
14. Weickert, C.S., Straub, R.E., McClintock, B.W., Matsumoto, M., Hashimoto, R., Hyde, T.M., Herman, M.M., Weinberger, D.R. and Kleinman, J.E. (2004) Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry, 61, 544-555.
15. Talbot, K., Eidem, W.L., Tinsley, C.L., Benson, M.A., Thompson, E.W., Smith, R.J., Hahn, C.G., Siegel, S.J., Trojanowski, J.Q., Gur, R.E. et al. (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest., 113, 1353-1363.
16. Gur, R.C., Moelter, S.T. and Ragland, J.D. (2000) Learning and memory in schizophrenia. In Sharma, T. and Harvey, P. (eds), Cognition in Schizophrenia: Impairments, Importance, and Treatment Strategies, Oxford University Press, New York, pp. 73-91.
17. Goldberg, T.E., David, A. and Gold, J.M. (2003) Neurocognitive deficits in schizophrenia. In Hirsch, S.R. and Weinberger, D.R. (eds), Schizophrenia, Blackwell Publishing, Malden, MA, pp. 168-184.
18. van den Oord, E.J.C.G., Sullivan, P.F., Jiang, Y., Walsh, D., O'Neill, F.A., Kendler, K.S. and Riley, B.P. (2003) Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry, 8, 499-510.
19. Fanous, A.H., van den Oord, E.J., Riley, B.P., Aggen, S.H., Neale, M.C., O'Neill, F.A., Walsh, D. and Kendler, K.S. (2005) Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am. J. Psychiatry, 162, 1824-1832.
20. Gornick, M.C., Addington, A.M., Sporn, A., Gogtay, N., Greenstein, D., Lenane, M., Gochman, P., Ordonez, A., Balkissoon, R., Vakkalanka, R. et al. (2005) Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J. Autism Dev. Disor., 35, 831-838.
21. Straub, R.E., Egan, M.F., Hashimoto, R., Matsumoto, M., Weickert, C.S., Goldberg, T.E., Callicott, J.H., Hyde, T.M., Kleinman, J.E. and Weinberger, D.R. (2003) The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): Analysis of haplotypes, intermediate phenotypes and alternative transcripts. Biological Psychiatry, 53 (suppl.), 167S-168S.
22. Burdick, K.E., Lencz, T., Funke, B., Finn, C.T., Szeszko, P.R., Kane, J.M., Kucherlapati, R. and Malhotra, A.K. (2006) Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet., 15, 1563-1568.
23. Fallgatter, A.J., Herrmann, M.J., Hohoff, C., Ehlis, A.C., Jarczok, T.A., Freitag, C.M. and Deckert, J. (2006) DTNBP1 (Dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology, Vol. 31, (published online ahead of print, DOI: 10.1038/sj.npp.1301003).
24. Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N., Ozaki, N., Taguchi, T., Tatsumi, M., Kamijima, K. et al. (2004) Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet., 13, 2699-2708.
25. Myhrer, T. (2003) Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks. Brain Res. Rev., 41, 268-287.
26. Riedel, G., Platt, B. and Micheau, J. (2003) Glutamate receptor function in learning and memory. Behav. Brain Res., 140, 1-47.
27. Coyle, J.T. (2004) The GABA-glutamate connection in schizophrenia: Which is the proximate cause? Biochem. Pharmacol., 68, 1507-1514.
28. Konradi, C. and Heckers, S. (2003) Molecular aspects of glutamate dysregulation: Implications for schizophrenia and its treatment. Pharmacol. Ther., 97, 153-179.
29. Lewis, D.A., Hashimoto, T. and Volk, D.W. (2005) Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci., 6, 312-324.
30. Benson, M.A., Tinsley, C.L. and Blake, D.J. (2004) Myospryn is a novel binding partner for dysbindin in muscle. J. Biol. Chem., 279, 10450-10458.
31. Starcevic, M. and Dell'Angelica, E.C. (2004) Identification of snapin and three novel proteins (BLOS1, BLOS2 and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J. Biol. Chem., 279, 28393-28401.
32. Nazarian, R., Starcevic, M., Spencer, M.J. and Dell'Angelica, E.C. (2006) Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein. Biochem. J., 395, 587-598.
33. Ilardi, J.M., Mochida, S. and Sheng, Z.H. (1999) Snapin: A SNARE-associated protein implicated in synaptic transmission. Nat. Neurosci., 2, 119-124.
34. Tian, J.H., Wu, Z.X., Unzicker, M., Lu, L., Cai, Q., Li, C., Schirra, C., Matti, U., Stevens, D., Deng, C. et al. (2005) The role of snapin in neurosecretion: Snapin knock-out mice exhibit impaired calcium-dependent exocytosis of large dense-core vesicles in chromaffin cells. J. Neurosci., 25, 10546-10555.
35. Li, W., Zhang, Q., Oiso, N., Novak, E.K., Gautam, R., O'Brien, E.P., Tinsley, C.L., Blake, D.J., Spritz, R.A., Copeland, N.G. et al. (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet., 35, 84-89.
36. Phillips, G.R., Huang, J.K., Wang, Y., Tanaka, H., Shapiro, L., Zhang, W., Shan, W.S., Arndt, K., Frank, M., Gordon, R.E. et al. (2001) The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution. Neuron, 32, 63-77.
37. Phillips, G.R., Florens, L., Tanaka, H., Khaing, Z.Z., Fidler, L., Yates, J.R., 3rd. and Colman, D.R. (2005) Proteomic comparison of two fractions derived from the transsynaptic scaffold. J. Neurosci. Res., 81, 762-775.
38. Chen, M., Lucas, K.G., Akum, B.F., Balasingam, G., Stawicki, T.M., Provost, J.M., Riefler, G.M., Jornsten, R.J. and Firestein, B.L. (2005) A novel role for snapin in dendrite patterning: Interaction with cypin. Mol. Biol. Cell, 16, 5103-5114.
39. Insausti, R. and Amaral, D.G. (2004) Hippocampal formation. In Paxinos, G. and Mai, J. (eds), The Human Nervous System., 2nd ed. Academic Press, New York, pp. 871-914.
40. Buckmaster, P.S., Strowbridge, B.W., Kunkel, D.D., Schmiege, D.L. and Schwartzkroin, P.A. (1992) Mossy cell axonal projections to the dentate gyrus molecular layer in the rat hippocampal slice. Hippocampus, 2, 349-362.
41. Buckmaster, P.S., Wenzel, H.J., Kunkel, D.D. and Schwartzkroin, P.A. (1996) Axon arbors and synaptic connections of hippocampal mossy cells in the rat in vivo. J. Comp. Neurol., 366, 271-292.
42. Li, X.G., Somogyi, P., Ylinen, A. and Buzsaki, G. (1994) The hippocampal CA3 network: An in vivo intracellular labeling study. J. Comp. Neurol., 339, 181-208.
43. Wenzel, H.J., Buckmaster, P.S., Anderson, N.L., Wenzel, M.E. and Schwartzkroin, P.A. (1997) Ultrastructural localization of neurotransmitter immunoreactivity in mossy cell axons and their synaptic targets in the rat dentate gyrus. Hippocampus, 7, 559-570.
44. Frotscher, M., Seress, L., Schwerdtfeger, W.K. and Buhl, E. (1991) The mossy cells of the fascia dentata: A comparative study of their fine structure and synaptic connections in rodents and primates. J. Comp. Neurol., 312, 145-163.
45. Ribak, C.E., Seress, L. and Amaral, D.G. (1985) The development, ultrastructure and synaptic connections of the mossy cells of the dentate gyrus. J. Neurocytol., 14, 835-857.
46. Scharfman, H.E. (1991) Dentate hilar cells with dendrites in the molecular layer have lower thresholds for synaptic activation by perforant path than granule cells. J. Neurosci., 11, 1660-1673.
47. Hetherington, P.A., Austin, K.B. and Shapiro, M.L. (1994) Ipsilateral associational pathway in the dentate gyrus: An excitatory feedback system that supports N-methyl-D-aspartate-dependent long-term potentiation. Hippocampus, 4, 422-438.
48. Freund, T.F. and Buzsaki, G. (1996) Interneurons of the hippocampus. Hippocampus, 6, 347-470.
49. Sik, A., Penttonen, M. and Buzsaki, G. (1997) Interneurons in the hippocampal dentate gyrus: An in vivo intracellular study. Eur. J. Neurosci., 9, 573-588.
50. Vizi, E.S. and Kiss, J.P. (1998) Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions. Hippocampus, 8, 566-607.
51. Andersen, P., Blackstad, T.W. and Lomo, T. (1966) Location and identification of excitatory synapses on hippocampal pyramidal cells. Exp. Brain Res., 1, 236-248.
52. Nusser, Z., Lujan, R., Laube, G., Roberts, J.D., Molnar, E. and Somogyi, P. (1998) Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron, 21, 545-559.
53. Ishizuka, N., Weber, J. and Amaral, D.G. (1990) Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J. Comp. Neurol., 295, 580-623.
54. Swanson, L.W., Sawchenko, P.E. and Cowan, W.M. (1980) Evidence that the commissural, associational and septal projections of the regio inferior of the hippocampus arise from the same neurons. Brain Res., 197, 207-212.
55. Vites, O., Rhee, J.S., Schwarz, M., Rosenmund, C. and Jahn, R. (2004) Reinvestigation of the role of snapin in neurotransmitter release. J. Biol. Chem., 279, 26251-26256.
56. Thakur, P., Stevens, D.R., Sheng, Z.H. and Rettig, J. (2004) Effects of PKA-mediated phosphorylation of Snapin on synaptic transmission in cultured hippocampal neurons. J. Neurosci., 24, 6476-6481.
57. 2+ accumulations and metabotropic glutamate receptor activation associated with an N-methyl-D-aspartate receptor-independent long-term potentiation in hippocampal CA1 neurons. Hippocampus, 4, 546-558.
58. Chou, J.L., Huang, C.L., Lai, H.L., Hung, A.C., Chien, C.L., Kao, Y.Y. and Chern, Y. (2004) Regulation of type VI adenylyl cyclase by snapin, a SNAP25-binding protein. J. Biol. Chem., 279, 46271-46279.
59. Mons, N., Harry, A., Dubourg, P., Premont, R.T., Iyengar, R. and Cooper, D.M. (1995) Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration at synapses. Proc. Natl Acad. Sci. USA, 92, 8473-8477.
60. Garcia-Galloway, E., Arango, C., Pons, S. and Torres-Aleman, I. (2003) Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling. Mol. Cell. Neurosci., 24, 1027-1037.
61. Black, J.E., Kodish, I.M., Grossman, A.W., Klintsova, A.Y., Orlovskaya, D., Vostrikov, V., Uranova, N. and Greenough, W.T. (2004) Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am. J. Psychiatry, 161, 742-744.
62. Kalus, P., Bondzio, J., Federspiel, A., Muller, T.J. and Zuschratter, W. (2002) Cell-type specific alterations of cortical interneurons in schizophrenic patients. Neuroreport, 13, 713-717.
63. Kalus, P., Muller, T.J., Zuschratter, W. and Senitz, D. (2000) The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport, 11, 3621-3625.
64. Grady, R.M., Zhou, H., Cunningham, J.M., Henry, M.D., Campbell, K.P. and Sanes, J.R. (2000) Maturation and maintenance of the neuromuscular synapse: Genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron, 25, 279-293.
65. Maddox, P.H. and Jenkins, D. (1987) 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. J. Clin. Pathol., 40, 1256-1260.
66. Ribeiro-Da-Silva, A., Priestley, J.V. and Cuello, C. (1993) Pre-embedding ultrastructural immunocytochemistry. In Cuello, A.C. (ed), Immunohistochemistry II, John Wiley, New York, pp. 181-227.
67. Llewellyn-Smith, I.J. and Minson, J.B. (1992) Complete penetration of antibodies into vibratome sections after glutaraldehyde fixation and ethanol treatment: Light and electron microscopy for neuropeptides. J. Histochem. Cytochem., 40, 1741-1749.
68. Teclemariam-Mesbah, R., Wortel, J., Romijn, H.J. and Buijs, R.M. (1997) A simple silver-gold intensification procedure for double DAB labeling studies in electron microscopy. J. Histochem. Cytochem., 45, 619-621.